Apollomics
APLM
5 hedge funds and large institutions have $129K invested in Apollomics in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 8 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.93% less ownership
Funds ownership: 2.09% → 1.17% (-0.93%)
55% less funds holding
Funds holding: 11 → 5 (-6)
60% less capital invested
Capital invested by funds: $323K → $129K (-$194K)
75% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$429 |
| 2 |
ETC
Exchange Traded Concepts
Oklahoma City,
Oklahoma
|
+$12 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$77.2K |
| 2 |
PIA
Powell Investment Advisors
Miami,
Florida
|
-$18.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$13.3K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$9.69K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$8.14K |
APLM Hedge Fund Activity: Q4 2024 in Review
5 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Apollomics (APLM) for Q4 2024, worth a combined $129K — down 60% from $323K a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of APLM and 2 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $429. The largest seller was Citadel Advisors, exiting entirely with an estimated $77.2K sold.
- 5 institutional investors held Apollomics (APLM) as of Q4 2024, down from 11 in Q3 2024.
- Funds reported $129K of Apollomics stock for Q4 2024, down 60% quarter-over-quarter.
- 2 funds opened new Apollomics positions in Q4 2024 and 8 closed out, a net change of -6 holders.
- The largest Apollomics buyer in Q4 2024 was Tower Research Capital (TRC), an estimated $429 added.
- The largest Apollomics seller in Q4 2024 was Citadel Advisors, an estimated $77.2K sold.
Based on aggregated 13F filings for Q4 2024.